Mural Oncology

We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein...

Immuno-oncology,cytokine biology,cancer,drug discovery,nemvaleukin alfa,interleukin-18,interleukin-12,immune cell modulation,protein engineering,cytokine therapies,immunotherapy,nemvaleukin,platinum-resistant ovarian cancer,ovarian cancer,proinflammatory cytokines,and mucosal melanoma

Mural oncology operates in the Biotechnology research industry.

Mural oncology's revenue is 11m - 100m

Mural oncology has 51 - 200 employees.